Editor’s Choice: Telemedicine and a Surprising Double Diagnosis

Happy Friday!

July is almost over, which means that Juvenile Idiopathic Arthritis Awareness Month is drawing to a close. But it’s not too late to bring attention to this often overlooked disease, this month or any other, and we have some ideas here. In this week’s Editor’s Choice, we have details on an FDA approved app that helps assist patients with neurological disorders. We also have a look at how telemedicine has helped with continuation of care for cancer patients. And finally, we have a story about a man who was hospitalized with a unexpected double diagnosis: Guillain-Barré syndrome and COVID-19. We hope you enjoy your weekend!

 

FDA-Approved App Coordinates Neuromodulation Therapies

Developed by Abbott, the Patient Controller App offers unique telemedicine at an important time.

 

Telemedicine for Cancer Patients During a Pandemic

The pandemic has made it difficult to get the same healthcare that we are used to. It is even harder for those who live with a medical condition or serious disease, such as cancer.

 

Mike’s Story: Overcoming COVID-19 and Guillain-Barré Syndrome

Following hospitalization, Mike received a shock; he had both COVID-19 and Guillain-Barré syndrome.

 


Do you have a rare disease experience of your own? Share with us here.

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email
Close Menu